Total Payments
$78,174
2024 Payments
$1,262
Companies
21
Transactions
297
Medicare Patients
663
Medicare Billing
$45,045
Payment Breakdown by Category
Consulting$58,840 (75.3%)
Travel$12,901 (16.5%)
Food & Beverage$6,314 (8.1%)
Other$100.00 (0.1%)
Education$10.00 (0.0%)
Gifts$9.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,840 | 23 | 75.3% |
| Travel and Lodging | $12,901 | 63 | 16.5% |
| Food and Beverage | $6,314 | 206 | 8.1% |
| Honoraria | $100.00 | 1 | 0.1% |
| Education | $10.00 | 1 | 0.0% |
| Gift | $9.99 | 1 | 0.0% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
General
$78,174
295 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vapotherm Inc | $74,957 | 153 | $0 (2024) |
| Novo Nordisk Inc | $842.42 | 59 | $0 (2024) |
| Merz North America, Inc. | $506.10 | 6 | $0 (2019) |
| Lilly USA, LLC | $317.79 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $317.64 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.63 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $150.56 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $141.60 | 6 | $0 (2024) |
| Genentech USA, Inc. | $124.99 | 1 | $0 (2017) |
| Welch Allyn | $100.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,262 | 45 | Vapotherm Inc ($407.00) |
| 2023 | $775.20 | 41 | Novo Nordisk Inc ($245.17) |
| 2022 | $616.29 | 21 | Vapotherm Inc ($376.08) |
| 2021 | $703.90 | 27 | Vapotherm Inc ($409.87) |
| 2020 | $459.00 | 9 | Vapotherm Inc ($348.00) |
| 2019 | $53,908 | 114 | Vapotherm Inc ($53,384) |
| 2018 | $20,211 | 36 | Vapotherm Inc ($20,033) |
| 2017 | $239.46 | 4 | Genentech USA, Inc. ($124.99) |
All Payment Transactions
297 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Obesity | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Vapotherm Inc | VAPOTHERM (Device) | Consulting Fee | Cash or cash equivalent | $407.00 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Obesity | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: Obesity | ||||||
| 08/12/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $25.94 | General |
| 08/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: DIABETES | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Obesity | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Oncology | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 149 | 197 | $15,190 | $9,875 |
| 2022 | 7 | 228 | 420 | $29,869 | $15,316 |
| 2021 | 5 | 211 | 303 | $18,575 | $11,874 |
| 2020 | 2 | 75 | 161 | $11,881 | $7,981 |
Total Patients
663
Total Services
1,081
Medicare Billing
$45,045
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 125 | $8,125 | $5,241 | 64.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 39 | $3,735 | $2,761 | 73.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 15 | $2,250 | $1,316 | 58.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,080 | $557.05 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 215 | $14,019 | $9,359 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 46 | $4,370 | $3,028 | 69.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 35 | 44 | $2,995 | $1,755 | 58.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 18 | $3,329 | $706.70 | 21.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 11 | 12 | $1,614 | $417.27 | 25.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 19 | 33 | $3,063 | $26.89 | 0.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 14 | 52 | $480.00 | $23.44 | 4.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 124 | $8,938 | $5,929 | 66.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 41 | 66 | $4,197 | $2,414 | 57.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 24 | $3,000 | $1,349 | 45.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 43 | 43 | $1,290 | $1,247 | 96.6% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 46 | 46 | $1,150 | $935.00 | 81.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 62 | 139 | $9,131 | $6,690 | 73.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 22 | $2,750 | $1,290 | 46.9% |
About Dr. Kirk Hinkley, MD
Dr. Kirk Hinkley, MD is a Emergency Medicine healthcare provider based in Hallstead, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366484198.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kirk Hinkley, MD has received a total of $78,174 in payments from pharmaceutical and medical device companies, with $1,262 received in 2024. These payments were reported across 297 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($58,840).
As a Medicare-enrolled provider, Hinkley has provided services to 663 Medicare beneficiaries, totaling 1,081 services with total Medicare billing of $45,045. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, Emergency Medicine
- Location Hallstead, PA
- Active Since 06/13/2006
- Last Updated 03/04/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1366484198
Products in Payments
- Precision Flow (Device) $73,765
- VAPOTHERM (Device) $1,092
- XEOMIN (Biological) $506.10
- Ozempic (Drug) $404.77
- Wegovy (Drug) $302.84
- MOUNJARO (Drug) $177.78
- TRELEGY ELLIPTA (Drug) $164.00
- ELIQUIS (Drug) $156.40
- TRULICITY (Drug) $127.90
- TRADJENTA (Drug) $125.33
- Rybelsus (Drug) $123.50
- FARXIGA (Drug) $106.51
- JARDIANCE (Drug) $101.41
- Otoscope (Device) $100.00
- Vivitrol 380 mg (Drug) $88.19
- Otezla (Drug) $84.50
- Cologuard Collection Kit (Device) $80.31
- Puraply (Medical Supply) $55.72
- AIRSUPRA (Drug) $44.05
- i-STAT portable clinical analyzer (Device) $40.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.